Emmaus Life Sciences, Inc

Emmaus Life Sciences, Inc. is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments and therapies, primarily focusing on rare and orphan diseases. Emmaus Life Sciences, Inc. is committed to improving the lives of individuals affected by these conditions, with a strong emphasis on addressing unmet medical needs.

The company's primary focus is on Sickle Cell Disease, a genetic disorder. Emmaus Life Sciences, Inc.’s lead product candidate is an oral pharmaceutical grade L-glutamine treatment that demonstrated positive clinical results in a completed Phase 3 clinical trial for sickle cell anemia and sickle ß0-thalassemia. Emmaus Life Sciences, Inc. is located at 21250 Hawthorne Blvd, Torrance, CA 90503, US.

Emmaus Life Sciences, Inc. is poised to make significant contributions to the field of biopharmaceuticals, driven by a commitment to innovation and patient-centric solutions. We invite the manager of Emmaus Life Sciences, Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance your company's visibility and commercial development.